Admasu Gizaw | Medicine and Health Sciences | Best Researcher Award

Posted on by ScienceFather

Admasu Gizaw | Medicine and Health Sciences | Best Researcher Award

Mr Admasu Gizaw, Jimma University, Ethiopia

Admasu Gizaw, MScN, Ph.D. Fellow🎓🩺 is an esteemed nursing educator and researcher at Jimma University, Ethiopia. With an MSc in Adult Health Nursing (2010) and currently pursuing a Ph.D. in Nursing, his research focuses on patient-centered care and nursing standards. He has over 14 years of experience, serving as a lecturer, CPD officer, and program coordinator. His expertise spans mentorship, curriculum development, and systematic reviews. A dedicated contributor to national nursing policies, he has authored impactful studies on public health and nursing practice. Proficient in statistical software 📊, he actively advances Ethiopia’s healthcare education and nursing profession. 🚑📚

Publication Profile

Scopus

Education

Admasu Gizaw 🎓 is an experienced nursing professional specializing in Adult Health Nursing (Medical-Surgical Nursing). He earned his MScN from Jimma University in 2010, focusing on nurses’ intention to stay in the profession 🏥. Currently, he is a Ph.D. Fellow in Nursing at Jimma University (since 2023), researching person-centered nursing care and its outcomes in Ethiopian university hospitals 💡. His journey began with a BScN in Nursing from Jimma University (2004-2006) 🩺. With a strong academic and research background, he is dedicated to improving nursing care and fostering better healthcare environments in Ethiopia 🌍.

Experience

Admasu Gizaw is a dedicated nursing professional with extensive experience in surgical and academic settings 🏥👨‍⚕️. He began his career as a staff nurse in the operating theatre (2003-2004 E.C) before advancing to head nurse (2004-2005 E.C) and later serving as Vice Nursing Service Director at JUMC (2007-2008 E.C) 🌟. He also worked as Delegate Nursing Service Director (Dec-June 2008 E.C). With over nine years as a lecturer and Assistant Professor at Jimma University (since May 2016) 🎓, he coordinated the Operation Theatre Nursing Specialty Program (2017-2020) and currently serves as CPD Officer at Jimma University Institute of Health (since Feb 2023) 📚.

Certificate Awarded Training

Mr. Admasu Gizaw has made significant contributions to the nursing field in Ethiopia, particularly in course development and training. Notably, he has developed and trained courses on Safe Operation Theatre, Nursing Documentation and Reporting, Wound Care, Body Fluid Management, and Nursing Process Application for organizations like Jimma University, Ethiopian Nurses Association, and the Ministry of Health. His work includes the preparation of national nursing standards, undergraduate program guidelines, and licensure examination blueprints. Mr. Gizaw has also been involved in the development of nursing curricula and earned certificates of contribution and recognition from various prestigious institutions. 🎓🩺📚🇪🇹

Research Focus

Admasu Gizaw’s research primarily focuses on public health issues, particularly in low-resource settings. His studies examine global and regional health burdens, with specific attention to allergic disorders, meningitis, reproductive health, and chronic conditions like hypertension. He has contributed significantly to understanding the risk factors and prevalence of various diseases, including cancer and labor induction. His work also delves into the predictors of moral distress among healthcare workers and factors affecting health service utilization, especially in Ethiopian populations. Gizaw’s research aims to improve healthcare delivery and policy through evidence-based insights. 📊🌍🩺💉

Publication Top Notes

Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019

Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

Predictors of Induction of Labor and Success Rate Among Mothers Giving Birth at Jimma University Medical Centre South West Ethiopia: Unmatched Case Control Study

Lifestyle modification practices and associated factors among hypertensive patients at Gambella Hospital Southwest Ethiopia; 2019

Predictors of moral distress among nurses working in Jimma University Medical Center, South West Ethiopia

Cancer Warning Symptoms Awareness and Associated Factors Among Individuals Living in Assella Town, Ethiopia

Reproductive health service utilization and associated factors among adolescents at public school in Adama Town east Shewa Ethiopia, 2018

 

Sangil Park | Medical Hypotheses | Best Researcher Award

Posted on by ScienceFather

Sangil Park | Medical Hypotheses | Best Researcher Award

Prof Sangil Park, Department of Neurology, Uijeongbu Eulji Medical Center, South Korea

Prof. Sangil Park is a dedicated neurologist and clinical researcher with expertise in stroke, neurocritical care, and neuro-intervention. 🧠💉 He serves as a Clinical Assistant Professor at Uijeongbu Eulji Medical Center and has completed fellowships in radiology, neurology, and critical care. 🌟📚 Holding a Ph.D. from Kyung Hee University, Dr. Park is certified in neurology, acute stroke care, and critical care medicine. 🎓🏅 His research includes innovative treatments for vascular diseases and digital health applications. 🩺📊 An active member of multiple neurological societies, he has published extensively and presented at international conferences. 🌍📝 Dr. Park’s work reflects a passion for advancing neurological care. ✨

Publication Profile

Orcid

Education 

Prof. Sangil Park boasts an impressive educational journey and certifications in medicine and engineering. He earned his Ph.D. in Medicine from Kyung Hee University (2023) 🧑‍🎓, where he also completed his M.D. (2014) 🩺. Prior to this, he obtained a B.D. in Electrical Engineering and Computer Science from Hanyang University (2009) 💻. Prof. Park holds the Korean Board of Neurology (2022) 🧠, the Certification of TPI from The Korean Orthopedic Pain Society (2022) 🏥, and the Subspecialty Board of Critical Care Medicine (2024) 🫀. Additionally, he is a certified Acute Stroke Neurologist (2024) ⚡, blending expertise in neurology and technology.

Career Background 

Prof. Sangil Park is a dedicated neurologist with extensive clinical experience and academic achievements. Since March 2024, he has been serving as a Clinical Assistant Professor at Uijeongbu Eulji Medical Center 🏥. He previously held fellowships in Radiology at Asan Medical Center (2023-2024) and in Neurology and Critical Care Medicine at Kyung Hee University Medical Center (2022-2023) 🔬🧠. Prof. Park completed his Neurology residency at Kyung Hee University Hospital at Gangdong (2018-2022) and internship at Kyung Hee University Medical Center (2017-2018) 👨‍⚕️. His military service included working as a public health doctor in Changnyeong-gun (2014-2017) 🚑🇰🇷.

Experience

Prof. Sangil Park’s groundbreaking work focuses on neurological and cerebrovascular health through advanced clinical research. 🌟🧠 He led a post-marketing safety study on Emgality (Galcanezumab) for migraine prophylaxis in adults in Korea (SIT, PMS2020-014-005) 💊, and explored neuroprotection with neu2000 in acute ischemic stroke patients through a phase-III randomized trial (2021-10-090). 🔬 In another study, he evaluated atrial fibrillation’s prevalence and impact in elderly patients with cryptogenic stroke and patent foramen ovale (2021-04-034). 💓 His contributions extend to assessing Choline Alfoscerate’s safety and efficacy in mild cognitive impairment with cerebrovascular disease in a phase-IV trial (2021-07-094). 🧪📈

Presentation 

Prof. Sangil Park has contributed extensively to stroke and neurovascular research. Key presentations include delayed post-hypoxic leukoencephalopathy after ischemic stroke at the 15th ESMINT Congress (2023) 🧠, and styloidogenic jugular venous compression syndrome at the Asia Pacific Stroke Conference (2022) 🩺. His studies on carotid artery restenosis after stenting at the 14th World Stroke Congress (2022) and predictors of in-stent restenosis at the KSIN Summer Intensive Course (2024) provide valuable insights 📊. Prof. Park has also explored COVID-19 vaccination’s link to ischemic stroke 🦠 and innovative treatments for cavernous sinus dural AVFs (2023) 🩸, advancing neurovascular care worldwide. 🌍

Professional Recognition 

Prof. Sangil Park is a dedicated neurologist with memberships in multiple prestigious societies, reflecting his commitment to advancing the field. 🌍📚 His consistent focus on cutting-edge research has significantly contributed to the understanding and treatment of neurological conditions. 🧠🔬 Specializing in stroke and neurocritical care, Prof. Park has made impactful strides in improving patient outcomes through collaborative research efforts. 🤝💡 His work bridges innovation and clinical application, ensuring better care for patients worldwide. 🏥🌟 A true leader in neurology, he continues to inspire progress in the field, shaping the future of neuroscience and neurocritical care. 🚀✨

Research Focus

Prof. Sangil Park’s research primarily focuses on neurovascular diseases, endovascular treatments, and innovative diagnostic approaches. His studies include targeted embolization for cavernous sinus dural arteriovenous fistulas 💉🧠, advanced imaging markers like the HARM sign for transient ischemic attacks 🩻🚨, and real-world applications of digital health technologies for chronic conditions like hypertension and diabetes 📱💊. His work extends to rare conditions, such as medullary hemangioblastomas and cerebral vasculitis 🩸🧬, reflecting a broad interest in improving patient outcomes through multidisciplinary approaches. His contributions to neurosonology and embolization emphasize precision medicine in neurology and radiology. 🌟📚

Publication Top Notes

Endovascular Treatment With Targeted Embolization of Cavernous Sinus Dural Arteriovenous Fistulas: A Single-Center Study

Hyperintense Acute Reperfusion Marker Sign in Patients with Diffusion Weighted Image-negative Transient Ischemic Attack HARM Sign in DWI-negative TIA

Ruptured Medullary Hemangioblastoma Mimicking a Craniocervical Junction Dural Arteriovenous Fistula with a Pseudoaneurysm

Real-World Evidence of a Hospital-Linked Digital Health App for the Control of Hypertension and Diabetes Mellitus in South Korea: Nationwide Multicenter Study

Real-World Evidence of a Hospital-Linked Digital Health App for the Control of Hypertension and Diabetes Mellitus in South Korea: Nationwide Multicenter Study (Preprint)

Klebsiella pneumoniae Cerebritis Masquerading as Hyperacute Middle Cerebral Artery Syndrome

Tracey Young-Sharma | Medicine and Health Sciences | Best Researcher Award

Posted on by ScienceFather

Tracey Young-Sharma | Medicine and Health Sciences | Best Researcher Award

Dr Tracey Young-Sharma, Ministry of Health and Medical Service FIji, Fiji

Dr. Tracey Young-Sharma is an accomplished physician specializing in internal medicine and antimicrobial resistance (AMR). She holds a Masters of Medicine from Fiji National University (2019) and has been awarded the ASID GOLD Medal. Currently an AMR consultant for the World Health Organization, Dr. Young-Sharma has held various roles, including Consultant Physician and Registrar at CWM Hospital. She has contributed to multiple studies on antimicrobial resistance and its impact in Fiji, with notable publications in The Lancet and JGAR. Dr. Young-Sharma is also the Chairperson of the Infection Prevention Control Committee at CWMH. 🏥🦠📚🌍

Publication Profile

Scopus

Education

Dr. Tracey Young-Sharma is a highly accomplished medical professional with a strong background in Internal Medicine. She completed her Masters of Medicine in Internal Medicine at Fiji National University in 2019. Prior to that, she earned a Postgraduate Diploma in Internal Medicine in 2016 and a Bachelor’s degree in Medicine and Surgery from the Fiji School of Medicine in 2010. Dr. Young-Sharma has been recognized for her excellence in the field, receiving the prestigious Australian Society of Infectious Disease (ASID) GOLD Medal Award 🏅💉. Her dedication to improving healthcare continues to inspire and impact the medical community. 👩‍⚕️🌟

Experience

Dr. Tracey Young-Sharma is an AMR consultant for the World Health Organisation (WHO) since August 2024 🌍. Previously, she served as a Consultant Physician at CWM Hospital (2022-2024) 🏥 and as a Registrar at the same hospital from 2016 to 2021. Prior to that, she worked as a Registrar in Internal Medicine at Labasa Hospital in 2015 🩺. Dr. Young-Sharma began her career as a Medical Officer at Levuka Hospital and Koro Health Centre (2012-2014) 🏥 and completed her internship at CWM Hospital in 2011. Her extensive experience spans various medical roles, contributing to healthcare development. 👩‍⚕️🌿

Professional Memberships 

Dr. Tracey Young-Sharma is a dedicated healthcare professional with strong affiliations in the medical field. She is an Associate Member of the Internal Medicine Society of Australia and New Zealand and a member of the Internal Medicine Organisation of the Pacific. Additionally, Dr. Young-Sharma is part of the International Women’s Association, the Fiji Medical Association, and the Australasian College of Infection Prevention and Control. In 2022, she served as the Chairperson of the Infection Prevention and Control Committee at CWMH. Her active roles reflect her commitment to advancing healthcare and fostering collaboration in the medical community. 🌍👩‍⚕️💉🩺

Research Focus

Dr. Tracey Young-Sharma’s research primarily focuses on antimicrobial resistance (AMR), particularly in resource-limited settings like Fiji. Her work involves genomic surveillance and epidemiological studies to understand the spread of carbapenem-resistant organisms and other multidrug-resistant pathogens. Dr. Young-Sharma’s studies also emphasize the impact of AMR on healthcare outcomes, including attributable mortality and length of hospital stays. She is also involved in improving healthcare workers’ knowledge and readiness to combat AMR through intervention studies. Her research aims to inform public health strategies and healthcare policies in the context of global AMR challenges. 🦠🔬🌍👩‍🔬💉

Publication Top Notes

Successful management of a multi-species outbreak of carbapenem-resistant organisms in Fiji: a prospective genomics-enhanced investigation and response

Knowledge, attitudes, and readiness about critical antimicrobial resistant organisms among healthcare workers at colonial war memorial hospital in Fiji: a pre and post intervention study

The epidemiology of enterococci in a tertiary hospital and primary healthcare facilities in Fiji (2019–2022)

The changing epidemiology of antimicrobial resistance in Fiji: a descriptive analysis of antimicrobial susceptibility and trends of endemic and emerging pathogens, 2019–2022

Attributable mortality and excess length of stay associated with third-generation cephalosporin-resistant Enterobacterales bloodstream infections: a prospective cohort study in Suva, Fiji

Epidemiology, antimicrobial resistance and outcomes of Staphylococcus aureus bacteraemia in a tertiary hospital in Fiji: A prospective cohort study